|
|
Speaker Proposals
being Accepted!
|
| |
| Register |
|
|
|
|
DELIVERING DRUGS FOR DIFFICULT TARGETS
8:30am Keynote Introduction
(Sponsorship Available)
8:40-9:40 Executive Panel: Delivering Drugs for Difficult Targets
|
Executive Panelists:
|
|
|
 |
Mikael Dolsten, Ph.D., Executive Vice President, Pharma Research,
Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Alexander Rod MacKenzie, Senior Vice President, Head of Worldwide Discovery Research, Pfizer
Inc.
|
|
|
|
|
 |
Lex Van der Ploeg, Vice President, Basic Research, Merck Research
Laboratories
|
 |
John J. Rossi, Ph.D., Lidow Family Research Chair, Professor, Division
of Molecular Biology, Dean, Graduate School of Biological Sciences, Beckman
Research Int. of City of Hope
|
|
|
|
|
 |
Shama Kajiji, Ph.D., MBA, Senior Director, Portfolio Franchise
Management Department, Merck and Co.
|
 |
Jesus "Tito" Gonzalez, Ph.D., Senior Director, Biology,
Vertex Pharmaceuticals Inc.
|
|
Panel Topics:
- Balancing the R&D Portfolio – Focus or Diversify?
- Translating Innovation into R&D Productivity
- Partnering with Biotech & Academia
- Accelerating Discovery & Development Success through;
- Investigating More Innovative Targets
- Improving the Quality of Validated Targets
- Improving Lead Generation & Optimization
- Employing Enabling Technologies
|
|
